Search Results - berzofsky

2 Results Sort By:
3-o-sulfo-galactosylceramide Analogs for Targeting Lung Metastases
Summary: The NCI seeks research co-development partners and/or licensees for the sulfatide analog, C24:2 Description of Technology: Lung metastases represent a major clinical challenge in advanced cancer, with poor survival rates and no effective therapies to prevent their development. Researchers at the National Cancer Institute (NCI) have developed...
Published: 4/24/2026   |   Updated: 8/2/2023   |   Inventor(s): Lise Pasquet, Jay Berzofsky, Amy Howell, Masaki Terabe, Kaddy Camara
Keywords(s): 3-o-sulfo-galactosylceramide Analogs, Berzofsky, C24:2, Immunotherapy, lung cancer, Metastasis, Natural Killer cells, NKT cells, Sulfatide Analogs, T Cells
Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Immunology
Biomarker Analysis Software for High-Throughput Diagnostic Multiplex Data
Summary: The NCI seeks research co-development partners and/or licensees for a biomarker analysis software for high-throughput diagnostic multiplex data. Description of Technology: Extracellular vesicles (EVs) are lipid bilayer-enclosed particles that are released from cells. EVs may contain proteins derived from their cells of origin with the potential...
Published: 4/23/2026   |   Updated: 8/2/2023   |   Inventor(s): Joshua Welsh, Jennifer Jones, Jay Berzofsky
Keywords(s): Berzofsky, Biomarker, EV, Extracellular Vesicles, High-throughput, Jones, Lipid Bilayer-Enclosed Particles, software
Category(s): Application > Software / Apps, TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing